Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial. Issue 11 (November 2017)
- Record Type:
- Journal Article
- Title:
- Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial. Issue 11 (November 2017)
- Main Title:
- Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer
- Authors:
- Upadhyaya, Arun
Zhou, Pingping
Meng, Zhaowei
Wang, Peng
Zhang, Guizhi
Jia, Qiang
Tan, Jian
Li, Xue
Hu, Tianpeng
Liu, Na
Wang, Sen
Liu, Xiaoxia
Wang, Huiying
Zhang, Chunmei
Zhao, Fengxiao
Yan, Ziyu
Wang, Xiaoran
Zhang, Xuemeng
Zhang, Wan - Abstract:
- Abstract : Objectives: This study aimed to examine the radioprotective effect of vitamin E on salivary glands after radioactive iodine ( 131 I) therapy in patients with differentiated thyroid cancer. Patients and methods: Eighty-two patients with differentiated thyroid cancer were enrolled in this study. They were divided randomly into four groups (control group: 22 cases, group A: 23 cases, group B: 22 cases, and group C: 15 cases) before postsurgical ablation therapy with 100 mCi 131 I. The patients in groups A, B, and C received vitamin E 100, 200, and 300 mg/day orally, respectively, for a duration of 1 week before to 4 weeks after 131 I therapy. Salivary gland function was assessed using salivary gland scintigraphy immediately before and 6 months after 131 I therapy. Uptake fraction (UF), uptake index (UI), excretion fraction (EF), and excretion ratio (ER) of each salivary gland were measured and compared. Results: On comparison between before and after 131 I therapy in the control group, there was a significant decrease in UF of both right and left parotid glands (all P <0.01). In group A, a significant increase in EF of the right parotid gland ( P <0.01) and UI of the right submandibular gland ( P <0.05) was found. In group B, there was a significant increase in UI of the right parotid gland and both submandibular glands (all P <0.01). In group C, there was a significant increase in UF of the left parotid gland ( P <0.05) and the right submandibular gland ( P <0.01).Abstract : Objectives: This study aimed to examine the radioprotective effect of vitamin E on salivary glands after radioactive iodine ( 131 I) therapy in patients with differentiated thyroid cancer. Patients and methods: Eighty-two patients with differentiated thyroid cancer were enrolled in this study. They were divided randomly into four groups (control group: 22 cases, group A: 23 cases, group B: 22 cases, and group C: 15 cases) before postsurgical ablation therapy with 100 mCi 131 I. The patients in groups A, B, and C received vitamin E 100, 200, and 300 mg/day orally, respectively, for a duration of 1 week before to 4 weeks after 131 I therapy. Salivary gland function was assessed using salivary gland scintigraphy immediately before and 6 months after 131 I therapy. Uptake fraction (UF), uptake index (UI), excretion fraction (EF), and excretion ratio (ER) of each salivary gland were measured and compared. Results: On comparison between before and after 131 I therapy in the control group, there was a significant decrease in UF of both right and left parotid glands (all P <0.01). In group A, a significant increase in EF of the right parotid gland ( P <0.01) and UI of the right submandibular gland ( P <0.05) was found. In group B, there was a significant increase in UI of the right parotid gland and both submandibular glands (all P <0.01). In group C, there was a significant increase in UF of the left parotid gland ( P <0.05) and the right submandibular gland ( P <0.01). Also, there was a statistical increase in UI in both submandibular glands (all P <0.01). However, on comparing the changes in the post- 131 I therapy salivary scintigraphy parameters among the four groups, there was a significant difference in ΔUI of the right parotid gland ( P <0.05) and both submandibular glands (all P <0.01), as well as ΔER of the left parotid gland ( P <0.05) and ΔUF of the left submandibular gland ( P <0.05). Conclusion: Vitamin E exerts significant protective effects on the parotid and submandibular glands after 131 I therapy. … (more)
- Is Part Of:
- Nuclear medicine communications. Volume 38:Issue 11(2017:Nov.)
- Journal:
- Nuclear medicine communications
- Issue:
- Volume 38:Issue 11(2017:Nov.)
- Issue Display:
- Volume 38, Issue 11 (2017)
- Year:
- 2017
- Volume:
- 38
- Issue:
- 11
- Issue Sort Value:
- 2017-0038-0011-0000
- Page Start:
- Page End:
- Publication Date:
- 2017-11
- Subjects:
- 131I therapy -- differentiated thyroid cancer -- salivary gland -- vitamin E
Nuclear medicine -- Periodicals
616.07575 - Journal URLs:
- http://journals.lww.com/nuclearmedicinecomm/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
http://www.lww.com/Product/0143-3636 ↗ - DOI:
- 10.1097/MNM.0000000000000727 ↗
- Languages:
- English
- ISSNs:
- 0143-3636
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6180.923000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 8317.xml